Exhibit
31.1
RULE
13a-14(a) CERTIFICATION
AS
ADOPTED PURSUANT TO SECTION 302
OF
THE
SARBANES-OXLEY ACT OF 2002
I,
Judy
M. Robinett, certify that:
1.
I have
reviewed this quarterly report on Form 10-QSB of Medical Discoveries, Inc.,
a
Utah corporation (the “registrant”);
2.
Based
on my knowledge, this quarterly report does not contain any untrue statement
of
a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements
were
made, not misleading with respect to the period covered by this quarterly
report;
3.
Based
on my knowledge, the financial statements, and other information included in
this quarterly report, fairly present in all material respects the financial
condition, results of operations and cash flows of the registrant as of, and
for, the periods presented in this quarterly report;
4.
I am
responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d -15(e)) for the registrant
and we have:
a)
Designed such disclosure controls and procedures to ensure that material
information relating to the registrant is made known to me by others within
those entities, particularly during the period in which this quarterly report
is
being prepared;
b)
Evaluated the effectiveness of the registrant’s disclosure controls and
procedures and presented in this quarterly report my conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this quarterly report based on such evaluation;
and
c)
Disclosed in this report any change in the small business issuer’s internal
control over financial reporting that occurred during the small business
issuer’s most recent fiscal quarter (the small business issuer’s fourth fiscal
quarter in the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the small business issuer’s internal
control over financial reporting; and
5.
I have
disclosed, based on my most recent evaluation of internal control over financial
reporting, to the registrant’s auditors and the audit committee of registrant’s
board of directors (or persons performing the equivalent function):
a)
All
significant deficiencies and material weaknesses in the design or operation
of
internal control over financial reporting which are reasonably likely to
adversely affect the registrant’s ability to record, process, summarize and
report financial information; and
b)
Any
fraud, whether or not material, that involves management or other employees
who
have a significant role in the registrant’s internal controls over financial
reporting.
Dated:
November 14, 2006
/s/
Judy
M. Robinett
Judy
M.
Robinett
President
and Chief Executive Officer